Date Name Title Filing Type Shares Traded Price Total Held
Apr 13, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 90,444 $10.56 157,540
Jun 12, 2006
Director
Director Form 4 Other acquisition or disposition (describe transaction) 112,387 -- 157,780
Jan 10, 2014
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Bona fide gift 764 -- 157,824
Dec 30, 2020
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 240,000 -- 158,079
Dec 16, 2011
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 158,079 -- 158,079
May 01, 2024
Director, Bd. Co-Chair, President & CSO
Director, Bd. Co-Chair, President & CSO Form 4 Other acquisition or disposition -- -- 158,410
May 01, 2024
Director, Bd. Co-Chair, President & CSO
Director, Bd. Co-Chair, President & CSO Form 4 Other acquisition or disposition -- -- 158,410
Feb 20, 2024
Director, Bd. Co-Chair, President & CSO
Director, Bd. Co-Chair, President & CSO Form 4 Other acquisition or disposition -- -- 158,410
Jan 04, 2024
Director, Bd. Co-Chair, President & CSO
Director, Bd. Co-Chair, President & CSO Form 4 Other acquisition or disposition -- -- 158,410
Dec 13, 2023
Director, Bd. Co-Chair, President & CSO
Director, Bd. Co-Chair, President & CSO Form 4 Other acquisition or disposition -- -- 158,410

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.